0124-4069864 info@fopeindia.com
CDSCO
Post Approval changes for clinical trials (Form CT-06) for CGTP through SUGAM Online Portal
29 October, 2025
Download
FOPE Newsletter
FOPE NEWSLETTER 57
24 October, 2025
Withdrawal of Covid-19 indication of Baricitinib Tablets 2mg & 4mg
23 October, 2025
DGFT
Amendment in Import Policy Condition of Sulfadiazine API covered under Chapter 29 of ITC HS 2022 ScheduleI Import Policy regarding
15 October, 2025
Notice for inviting comment to ensure a level playing field in new drug approval in India
08 October, 2025
Mapping of ICEGATE with CDSCO-Notified Ports
07 October, 2025
Strict compliance with the Drugs Rules 1945 for testing of raw materials and finished formulations
Clarification for grant of permission for combipack product of lyophilised dry powder for injection /I.V infusion and diluents for reconstitution such as sterile water for injection / sodium Chloride Injection
29 September, 2025
Circular Internal time-lines Procedures for RTI Appeals
22 September, 2025
FOPE NEWSLETTER 55
19 September, 2025
ICMR-CDSCO Standard Performance Evaluation Protocols
17 September, 2025
Clarification for regulatory pathway for Cocrystals
15 September, 2025
Corrigendum to the letter dated 11.04.2025 on manufacturing and marketing of unapproved FDCs
10 September, 2025
Inviting comments on consideration of the proposal regarding problem faced by the blind or visually impaired people to read medicines tablets/capsules strips
09 September, 2025
FOPE Secretariat
Online Webinar on "Navigating GST Reduction on Pharma-DPCO & Market Perspective"
08 September, 2025